Latest News in the pharma Industry

Top Stories

Pall Corp. to Acquire ForteBio

Pall Corp. to Acquire ForteBio

20 Dec 2011

The transaction is expected to close by February of 2012. ForteBio will become a wholly-owned subsidiary of Pall Corp.

Read more 
Amgen & Watson Sign for Oncology Biosimilars

Amgen & Watson Sign for Oncology Biosimilars

20 Dec 2011

Under the terms of the agreement, Amgen will assume primary responsibility for developing, manufacturing and initially commercializing the oncology antibody products.

Read more 
Pfizer & Glaxo Expand Supply Agreements for Pneumonia Vaccines

Pfizer & Glaxo Expand Supply Agreements for Pneumonia Vaccines

20 Dec 2011

Pfizer and GSK will supply hundreds of millions of additional doses of pneumonia vaccine to an international partnership for immunization to children in developing countries.

Read more 
Valeant Pharmaceuticals Proposes to Acquire ISTA

Valeant Pharmaceuticals Proposes to Acquire ISTA

19 Dec 2011

The proposed transaction has a total equity value of approximately $314 million on a fully diluted basis. In addition, ISTA has net debt of approximately $13 million, bringing the total enterprise value to approximately $327 million.

Read more 
Amgen CEO to Retire Next Year

Amgen CEO to Retire Next Year

19 Dec 2011

Mr. Sharer will step down as CEO effective May 23, 2012, and remain as chairman until December 31, 2012.

Read more 
Sygnature Extends Strategic Alliance with Cyprotex

Sygnature Extends Strategic Alliance with Cyprotex

19 Dec 2011

The two firms have signed an extension of their strategic alliance for a further two years to accelerate their clients’ drug discovery projects into development.

Read more 
UK Cancer Treatment Costs to Soar over Next Decade

UK Cancer Treatment Costs to Soar over Next Decade

16 Dec 2011

A new report says the costs associated with the diagnosis and treatment of cancer in the UK will dramatically increase by 2021.

Read more 
EMA Confirms Positive Benefit-risk Balance of Somatropin-Containing Medicines

EMA Confirms Positive Benefit-risk Balance of Somatropin-Containing Medicines

16 Dec 2011

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) confirms that the benefit-risk balance of somatropin-containing medicines remains positive.

Read more 
Enlight Teams up with AZ and Novo

Enlight Teams up with AZ and Novo

16 Dec 2011

Enlight Biosciences has formed new partnerships with UK-based AstraZeneca and Denmark-based Novo Nordisk for the development of potentially transformational technologies.

Read more 
Eisai Submits Aricept Application in Japan

Eisai Submits Aricept Application in Japan

15 Dec 2011

Eisai has submitted a marketing and manufacturing authorisation application in Japan to seek approval of a new dry syrup formulation of Aricept.

Read more 
Spanish CRO Kymos Signs Collaboration Agreement with French Ipsen

Spanish CRO Kymos Signs Collaboration Agreement with French Ipsen

15 Dec 2011

Kymos Pharma Services has signed an agreement with the French multinational group Ipsen to take in a team of eight scientists from Ipsen R&D Centre.

Read more 
Patient's Death Raises Questions over Novartis' MS Drug

Patient's Death Raises Questions over Novartis' MS Drug

15 Dec 2011

Since the approval, more than 28,000 patients have received the pill to date and no deaths have occurred until now.

Read more